Target intelligence / Profile preview

CABP1 divergent transcript (CABP1-DT)

Target
CABP1-DT
Molecular classification
Other
01

Overview

CABP1 divergent transcript (CABP1-DT) is an annotated non-coding transcript (lincRNA/divergent transcript) found at chromosome 12:120628830-120641922 on the reverse strand, according to Ensembl and NCBI Gene[5][9]. It is also listed as AC125616.1. There is currently no literature reporting a protein product, molecular function, or involvement in disease. Its naming and annotation indicate it is transcribed divergently from the CABP1 gene, which encodes Calcium binding protein 1, but there is no evidence that CABP1-DT itself is a receptor, enzyme, or other classical therapeutic target, nor are any interacting drugs or mechanisms of action known. There is no evidence currently of biological function, disease relevance, or use as a biomarker. Note: CABP1 divergent transcript should not be confused with the well-characterized protein-coding gene Calcium binding protein 1 (CABP1), which is involved in calcium signaling in neurons and is functionally distinct[3][11]. The divergent transcript is likely a lncRNA of unknown significance, with no established role as a therapeutic target.

Other names
AC125616.1CABP1-DT

Beyond the preview

Go deeper on CABP1 divergent transcript (CABP1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CABP1 divergent transcript (CABP1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call